tailieunhanh - Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: A comparison of different schedules and treatments

This open-label study compared docetaxel/gemcitabine vs. paclitaxel/gemcitabine and a weekly (W) vs. 3-weekly (3 W) schedule in metastatic breast cancer (MBC). Interim analysis led to accrual interruption (241 patients enrolled of 360 planned). Median TTP (months) was (95% CI: ) with W and (95% CI: ) with 3 W (p=). |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
337    145    2    25-12-2024
64    133    0    25-12-2024
18    129    0    25-12-2024